43 results on '"Eisenhauer, Elizabeth A."'
Search Results
2. An Interview With Dr Barbara A. Carper
3. Letter to the Editor
4. Molecular determinants of outcome with mammalian target of rapamycin inhibition in endometrial cancer
5. A phase I study of histone deacetylase inhibitor, pracinostat (SB939), in pediatric patients with refractory solid tumors: IND203 a trial of the NCIC IND program/C17 pediatric phase I consortium
6. Health education for Somali Bantu refugees via home visits
7. Speeding up the Evaluation of New Agents in Cancer
8. A phase II study of ispinesib (SB-715992) in patients with metastatic or recurrent malignant melanoma: a National Cancer Institute of Canada Clinical Trials Group trial
9. A phase II and pharmacokinetic study of SB-715992, in patients with metastatic hepatocellular carcinoma: A study of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG IND.168)
10. Phase II study of Triapine® in patients with metastatic renal cell carcinoma:: A trial of the National Cancer Institute of Canada Clinical Trials Group (NCIC IND.161)
11. A phase I study of oral LY293111 given daily in combination with irinotecan in patients with solid tumours
12. A phase II study of ZD6474 (Zactima™), a selective inhibitor of VEGFR and EGFR tyrosine kinase in patients with relapsed multiple myeloma–NCIC CTG IND.145
13. Gemcitabine Plus Carboplatin Compared With Carboplatin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer: An Intergroup Trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG
14. Recognition and Management of Methemoglobinemia and Hemolysis in a G6PD-Deficient Patient on Experimental Anticancer Drug Triapine
15. Phase II trial of DNA methyltransferase 1 inhibition with the antisense oligonucleotide MG98 in patients with metastatic renal carcinoma: A National Cancer Institute of Canada Clinical Trials Group investigational new drug study
16. Comparison of CA-125 and Standard Definitions of Progression of Ovarian Cancer in the Intergroup Trial of Cisplatin and Paclitaxel Versus Cisplatin and Cyclophosphamide
17. Phase II Trial of SarCNU in Malignant Glioma: Unexpected Pulmonary Toxicity with a Novel Nitrosourea: A phase II trial of the national cancer institute of canada clinical trials group
18. Phase II Study of Perifosine in Previously Untreated Patients with Metastatic Melanoma
19. A Phase I Pharmacokinetic and Pharmacodynamic Study of OGX-011, a 2′-Methoxyethyl Antisense Oligonucleotide to Clusterin, in Patients With Localized Prostate Cancer
20. Randomized Trial of Two Intravenous Schedules of the Topoisomerase I Inhibitor Liposomal Lurtotecan in Women With Relapsed Epithelial Ovarian Cancer: A Trial of the National Cancer Institute of Canada Clinical Trials Group
21. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
22. New guidelines to evaluate the response to treatment in solid tumors
23. Quality of Life in Ovarian Cancer Patients: Comparison of Paclitaxel Plus Cisplatin, With Cyclophosphamide Plus Cisplatin in a Randomized Study
24. Phase II trial of flavopiridol, a cyclin dependent kinase inhibitor, in untreated metastatic malignant melanoma
25. Phase I Trial Design for Solid Tumor Studies of Targeted, Non-Cytotoxic Agents: Theory and Practice
26. Phase I and pharmacokinetic study of fostriecin given as an intravenous bolus daily for five consecutive days
27. Re: New Guidelines to Evaluate the Response to Treatment in Solid Tumors (Ovarian Cancer)
28. A phase II study of topotecan in patients with anaplastic oligodendroglioma or anaplastic mixed oligoastrocytoma
29. Flavopiridol in Untreated or Relapsed Mantle-Cell Lymphoma: Results of a Phase II Study of the National Cancer Institute of Canada Clinical Trials Group
30. Phase I and Pharmacologic Study of the Human DNA Methyltransferase Antisense Oligodeoxynucleotide MG98 given as a 21-day Continuous Infusion Every 4 Weeks
31. Phase II study of marimastat (BB-2516) in malignant melanoma – A Clinical and Tumor Biopsy Study of the National Cancer Institute of Canada Clinical Trials Group
32. Ethics and industry-sponsored research
33. Multinomial Phase II Trial Designs
34. From the Molecule to the Clinic - Inhibiting HER2 to Treat Breast Cancer
35. In poor health: Supermarket redlining and urban nutrition
36. Phase I Dose-Finding Study of a New Taxane, RPR 109881A, Administered as a One-Hour Intravenous Infusion Days 1 and 8 to Patients With Advanced Solid Tumors
37. Palliative Effect of Chemotherapy: Objective Tumor Response Is Associated With Symptom Improvement in Patients With Metastatic Breast Cancer
38. New Guidelines to Evaluate the Response to Treatment in Solid Tumors
39. Re: Measure Once or Twice—Does It Really Matter?
40. Anticancer Agents Targeting Signaling Molecules and Cancer Cell Environment:Challenges for Drug Development?
41. Measuring Response in Solid Tumors: Unidimensional Versus Bidimensional Measurement
42. The Taxoids: Comparative Clinical Pharmacology and Therapeutic Potential
43. New drugs in gynecologic oncology
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.